经导管器械市场规模、份额及成长分析(按产品类型、应用和地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1897783

经导管器械市场规模、份额及成长分析(按产品类型、应用和地区划分)-2026-2033年产业预测

Transcatheter Devices Market Size, Share, and Growth Analysis, By Product Type (Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices), By Application (Cardiovascular, Oncology), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,全球经皮导管装置市场规模将达到 133.6 亿美元,到 2025 年将达到 151.2 亿美元,到 2033 年将达到 407.8 亿美元,预测期(2026-2033 年)的复合年增长率为 13.2%。

全球经导管器材市场反映了医疗保健领域的重要趋势,而微创手术的兴起是推动这一趋势的主要动力。这些创新器械因其能够治疗多种疾病,尤其是心血管疾病和结构性心臟疾病而备受青睐,它们能够实现精准治疗,最大限度地减少开胸手术的需求。推动市场发展的关键因素包括人口老化、慢性病盛行率上升以及医疗保健领域的技术进步。由于医护人员和病患都优先考虑恢復时间短、併发症少的治疗方法,经导管器械已成为极具吸引力的选择。然而,监管、报销以及所需的专业培训等方面的挑战可能会阻碍市场成长。预计未来的发展将继续得益于医疗保健领域持续不断的研究、创新和策略合作。

推动全球经导管器械市场发展的因素

全球导管类医疗器材市场受到医疗技术进步的显着影响,这些进步尤其註重提高病患舒适度和医疗服务效率。这些器械包括支架、瓣膜和栓塞工具,能够实现许多医学领域的微创手术。导管类医疗器械使医务人员能够透过微小切口而非传统的大型开放性手术进入身体特定部位,从而最大限度地减少患者的不适感并缩短恢復时间。随着患者越来越倾向于选择恢復更快、併发症风险更低的治疗方法,对这些创新器材的需求持续成长,推动医疗服务模式的改变。

全球经导管器械市场面临的限制因素

全球经导管器材市场面临许多挑战,因为开发和商业化这些先进医疗技术需要进行大量的临床试验并获得监管部门的核准。经导管手术的复杂性以及新技术固有的风险,都需要进行全面的评估,而病人安全始终是首要任务。此外,不同地区法规结构的差异也会进一步延迟产品上市,并增加製造商的成本。因此,这些监管障碍减缓了创新步伐,阻碍了产品及时进入市场,并成为限制经导管器械市场成长的重要阻碍因素。

全球经导管器材市场趋势

全球经导管器械市场正呈现显着成长趋势,经导管主动脉瓣置换术术(TAVR)作为一种微创治疗主动脉瓣疾病的方法,正日益受到青睐。这一增长主要归功于手术的诸多优势,例如恢復时间短、住院时间短、併发症少,使其对老年患者和手术风险高的患者特别具有吸引力。人口老化加剧,加之TAVR技术的不断进步,正推动其在全球各地更广泛的应用。此外,持续的研发和创新不断提升这些器械的性能,从而改善患者预后,并进一步促进市场成长。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管环境
  • 案例研究
  • 技术进步

全球经导管器材市场规模(依产品类型及复合年增长率划分)(2026-2033 年)

  • 经导管栓塞及闭塞装置
    • 线圈
  • 推式线圈
    • 可拆卸线圈
  • 非线圈
    • 血流分流装置
    • 栓塞颗粒
  • 液态栓塞剂
    • 其他栓塞及闭塞装置
    • 配件
  • 经导管置换装置
    • 经导管主动脉瓣置换术
    • 经导管肺动脉瓣置换术
    • 经导管二尖瓣置换术
  • 经导管瓣膜修復装置
    • 经导管二尖瓣瓣膜修復
    • 经导管三尖瓣修復术

全球经导管器材市场规模(按应用及复合年增长率划分)(2026-2033 年)

  • 循环系统
  • 肿瘤学
  • 神经病学
  • 泌尿系统
  • 其他的

全球经导管器材市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Edwards Lifesciences Corporation(USA)
  • Medtronic(USA)
  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • Bracco SpA(Italy)
  • JenaValve Technology Inc.(Germany)
  • CryoLife Inc.(USA)
  • Lepu Medical Technology Co. Ltd(China)
  • Transcatheter Technologies GmbH(Germany)
  • MicroPort Scientific Corporation(China)
  • Meril Life Sciences Pvt. Ltd(India)
  • St. Jude Medical Inc.(USA)
  • Direct Flow Medical Inc.(USA)
  • Heart Leaflet Technologies Inc.(USA)
  • Venus Medtech(China)
  • NVT AG(Germany)
  • Balton Sp. z oo(Poland)
  • New Valve Technology(Switzerland)
  • HLT Medical(USA)
  • Mardil Medical(USA)

结论与建议

简介目录
Product Code: SQMIG35A2584

Global Transcatheter Devices Market size was valued at USD 13.36 Billion in 2024 and is poised to grow from USD 15.12 Billion in 2025 to USD 40.78 Billion by 2033, growing at a CAGR of 13.2% during the forecast period (2026-2033).

The global transcatheter devices market reflects significant trends within the healthcare sector, driven by a shift towards minimally invasive procedures. These innovative devices are increasingly recognized for their ability to address various medical conditions, particularly cardiovascular diseases and structural heart defects, facilitating precise interventions that minimize the need for open surgeries. Key growth drivers include an aging population, rising chronic disease prevalence, and technological advancements in the medical field. As both healthcare professionals and patients prioritize treatments with expedited recovery and lower complication rates, transcatheter devices have become an attractive option. Nonetheless, challenges related to regulation, reimbursement, and necessary specialized training may hinder market growth. Future advancements will likely continue to stem from ongoing research, innovation, and strategic collaborations in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Devices Market Segments Analysis

Global Transcatheter Devices Market is segmented by Product Type, Application and region. Based on Product Type, the market is segmented into Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices and Transcatheter Repair Devices. Based on Application, the market is segmented into Cardiovascular, Oncology, Neurology, Urology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Devices Market

The global market for transcatheter devices is significantly influenced by advancements in medical technology that prioritize patient comfort and efficiency in healthcare delivery. These devices, which include stents, valves, and embolization tools, facilitate minimally invasive procedures across numerous medical fields. By enabling healthcare professionals to navigate to specific areas within the body through small incisions instead of traditional open surgeries, transcatheter devices help minimize patient discomfort and shorten recovery times. As patients increasingly favor treatments that offer faster healing and reduced risk of complications, the demand for these innovative devices continues to grow, driving transformation in treatment methodologies within the healthcare sector.

Restraints in the Global Transcatheter Devices Market

The global transcatheter devices market faces significant challenges due to the extensive clinical trials and regulatory approvals needed for the development and commercialization of these advanced medical technologies. The complexity of transcatheter procedures, along with the inherent risks linked to new innovations, necessitates thorough evaluations to prioritize patient safety. Moreover, the need to navigate various regulatory frameworks across different regions can further delay product launches and inflate costs for manufacturers. Consequently, these regulatory hurdles can slow down the pace of innovation and hinder timely market entry, serving as a considerable restraint on the growth of the transcatheter devices landscape.

Market Trends of the Global Transcatheter Devices Market

The Global Transcatheter Devices market is witnessing a notable trend towards the increasing adoption of Transcatheter Aortic Valve Replacement (TAVR) procedures as a preferred minimally invasive option for treating aortic valve diseases. This surge is largely attributed to the procedure's benefits, such as reduced recovery times, shorter hospital stays, and fewer complications, making it particularly appealing to elderly patients and those designated as high surgical risk. The growing geriatric population, coupled with continuous advancements in TAVR technology, is expanding its use across diverse regions. Additionally, ongoing research and innovation are enhancing these devices' capabilities, ensuring better patient outcomes and fostering market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Transcatheter Devices Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Transcatheter Embolization and Occlusion Devices
    • Coils
  • Pushable coils
    • Detachable coils
  • Non Coils
    • Flow Diverting Devices
    • Embolization Particles
  • Liquid Embolics
    • Other Embolization and Occlusion Devices
    • Accessories
  • Transcatheter Replacement Devices
    • Transcatheter Aortic Valve Replacement
    • Transcatheter Pulmonary Valve Replacement
    • Transcatheter Mitral Valve Replacement
  • Transcatheter Repair Devices
    • Transcatheter Mitral Valve Repair
    • Transcatheter Tricuspid Valve Repair

Global Transcatheter Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Cardiovascular
  • Oncology
  • Neurology
  • Urology
  • Others

Global Transcatheter Devices Market Size & CAGR (2026-2033)

  • North America (Product Type, Application)
    • US
    • Canada
  • Europe (Product Type, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bracco SpA (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JenaValve Technology Inc. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co. Ltd (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Transcatheter Technologies GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meril Life Sciences Pvt. Ltd (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Direct Flow Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heart Leaflet Technologies Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Venus Medtech (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NVT AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Balton Sp. z o.o. (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New Valve Technology (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HLT Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mardil Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations